ScubaTx raises £1.4m to advance organ preservation technology in Manchester.
- The new Manchester office marks a significant growth step for the Newcastle-based company.
- ScubaTx leverages ‘persufflation’ to extend the viability of donated organs.
- The firm aims to harness Manchester’s scientific expertise and foster new partnerships.
- The GMC Life Sciences Fund is a major backer, accelerating ScubaTx’s innovation.
ScubaTx, a prominent life sciences company, has secured £1.4m to further its groundbreaking work in organ preservation technology. This funding round, led by Praetura Ventures’ GMC Life Sciences Fund, comes on the heels of a successful £1.5m funding round last year.
The opening of a new office in Manchester signifies a pivotal moment for ScubaTx as it expands beyond its Newcastle roots. As a spinout from Newcastle University, the company continues its mission to revolutionise the organ transplantation process with its advanced technologies.
Central to ScubaTx’s innovation is the use of a process known as ‘persufflation’. This technique involves cooling and delivering humidified gas to oxygenate tissues at controlled pressures, thereby keeping donated organs viable for significantly longer periods.
The Manchester office employs 12 people, including six newly hired staff focused on operational and engineering capabilities. This strategic location enables the company to tap into the region’s renowned life sciences expertise, as well as foster engagement with potential commercial partners, particularly in the US.
CEO David Campbell notes, “Our new office at Manchester Science Park represents a real milestone… We’re excited to apply the local expertise and resources of Manchester’s rich life sciences innovation heritage.”
Investment Director Sim Singh-Landa of Praetura Ventures highlights that this funding phase allows ScubaTx to elevate its goal of transforming the organ transplantation field. Such advancements have the potential to increase the number of organs successfully transplanted, ultimately saving lives and reducing the stress on healthcare systems worldwide.
The expansion of ScubaTx into Manchester, supported by significant funding, heralds a transformative phase in organ transplantation technology.
